VEM Pharmaceuticals established in 2000. Since then, VEM Pharmaceuticals has been growing constantly in the Turkish pharmaceutical market which is one of the fastest growing pharmaceutical markets in the world. At the time being, it has been operating in an extending therapeutic area such as local anesthesia, cardiology, respiratory and infectious diseases. VEM has been operating its activities with "Quality products with Quality Service" principle.

While regulatory, finance and logistic functions are operated by the headquarters in Ankara, VEM also operates its marketing functions in the other sites of Turkey with covering whole country. The mission of the VEM Pharmaceuticals is providing the qualitative, high technology products to Turkish pharmaceutical market to answer the market needs and to improve the quality of life. VEM is the exclusive distributors of PanPharma (France), Demo (Greece), HELM (Germany), SoPharma (Bulgaria), S.E.R.P (Monaco) and Novocol (Canada); beside these VEM has the business collaborations with Boehringer Ingelheim, SIMS, Chemagis, Mallinckroat, Matrix LTD, BASF and Dr.Reddy's. Vem is planning to improve its position in Turkish and international pharmaceutical market with building business collaborations with leading multinational pharmaceutical companies and adding new products to its portfolio.